A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-muscle Invasive Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Contact: Study coordinator (Hailong Li M.D/Ph.D) · Justinlee719@163.com · 0086-17798835021

Study leads

Junnian Zheng, M.D/Ph.D
Study Director
The Affiliated Hospital of Xuzhou Medical University
Hailong Li, M.D/Ph.D
Principal Investigator
The Affiliated Hospital of Xuzhou Medical University
Meng Lu, Ph.D
Principal Investigator
The Affiliated Hospital of Xuzhou Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Non-muscle Invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

Bladder Cancer

Abroad (travel likely)RecruitingPHASE1

Nanjing, China

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Non-Muscle Invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bakersfield, United States · Tampa, United States